How a pharma in the multiple myeloma space gained access to leading KOLs insights and used them in its asset development process.
The Challenge: Understanding how KOLs define the treatment evolution and the…
How we helped a CNS mid-size pharma understand a new competitor in the EU after researching its sales force.
The Challenge: Assessing the impact of a new competitive entry in the CNS space…
How a mid-size pharma in the US asthma and COPD space edged out two new competitive threats by differentiating its education approaches
The Challenge: How to prepare when two new competitors enter your space Α…
How a large-cap pharma in the Direct Oral Anticoagulant Space (DOAC) space updated its promotional tactics to regain lost SoV
The Challenge: Stimulating conversation around your brand when your competitors…
How a large pharma in Hematology and Oncology space established and used competitive benchmarks across the US
The Challenge: Knowing field force performance against the competition A large…
How a leading global player in the respiratory space worked towards speedier access to Russia and China
The Challenge: Leading multinational Pharma company wants to dive deep into key…
How we helped a mid-size Pharma in the primary immunodeficiency (PID) space to respond successfully to a competitor's move.
The Challenge: Dealing with an existing competitor launching a new product.…
From Scarcity to Sufficiency: Understanding and Resolving the Cancer Drug Shortage in the United States
The US has been struggling with a severe cancer drug shortage for several…
Navigating the Immunoglobulin Therapy Landscape: An Overview
The Immunoglobulin Replacement Therapy (IG) market is growing, as these…
Can "Digital Vaccines" be a game-changer in lifestyle diseases?
Digital vaccines are clinically proven "no injection, no ingestion" vaccines.…
RSV vaccines: A powerful tool to protect against RSV
According tο a recent systematic analysis focusing on children younger than…
Declining confidence in childhood vaccines: A threat for today's kids.
"We cannot allow confidence in routine immunizations to become another victim…
